BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

GENZYME — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

GENZYME

via PODESTA GROUP, INC.

2nd Quarter (Apr 1 - June 30) · 2013Posted Jul 22, 2013Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: GENZYME
Location: District of Columbia · United States of America

Registrant

Firm: PODESTA GROUP, INC.
Description: Public policy, government relations and public affairs firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
340B issues. Patient Protection and Affordable Care Act (implementation).
LobbyistsANTHONY PODESTA · STEPHEN NORTHRUP · NORA CONNORS
Covered position (STEPHEN NORTHRUP): Health Policy Adviser, Sen. Michael Enzi
Covered position (NORA CONNORS): Leg. Assistant, Sen. Dianne Feinstein
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.